Literature DB >> 33953372

Immune dysfunction and reprogramming in RCC.

Rebecca Tregunna1.   

Abstract

Entities:  

Mesh:

Year:  2021        PMID: 33953372     DOI: 10.1038/s41585-021-00471-3

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN: 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  2 in total

1.  Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma.

Authors:  Kevin Bi; Meng Xiao He; Ziad Bakouny; Abhay Kanodia; Sara Napolitano; Jingyi Wu; Grace Grimaldi; David A Braun; Michael S Cuoco; Angie Mayorga; Laura DelloStritto; Gabrielle Bouchard; John Steinharter; Alok K Tewari; Natalie I Vokes; Erin Shannon; Maxine Sun; Jihye Park; Steven L Chang; Bradley A McGregor; Rizwan Haq; Thomas Denize; Sabina Signoretti; Jennifer L Guerriero; Sébastien Vigneau; Orit Rozenblatt-Rosen; Asaf Rotem; Aviv Regev; Toni K Choueiri; Eliezer M Van Allen
Journal:  Cancer Cell       Date:  2021-03-11       Impact factor: 31.743

Review 2.  Targeting cell-cycle machinery in cancer.

Authors:  Jan M Suski; Marcin Braun; Vladislav Strmiska; Piotr Sicinski
Journal:  Cancer Cell       Date:  2021-04-22       Impact factor: 38.585

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.